About Macrobian-Biotech

Macrobian-Biotech ( was founded in May 2017 by Dr. Lars van der Heide, Prof. Dr. Marten smidt, and the UvA-Holding. Its primary goal is to perform pre-clinical research that leads to novel treatments for disorders of the midbrain dopamine system. Research at Macrobian-Biotech is performed within the Swammerdam Institute of Life Sciences at the University of Amsterdam (, ensuring an excellent research climate. 


Science Park 904, 1098 XH, Amsterdam

View on Google Maps